Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Profile
Profile

Guangzhou Boji Medical and Biotechnology Co.,Ltd. (known as Boji biomedicals with the stock code of 300404) was founded in 2002 and listed on Shenzhen GEM in 2015. Boji is a new high-tech enterprise(CRO+CDMO) that provides one-stop service for domestic and abroad pharmaceutical enterprises, such as the R&D of drugs, medical devices and health products. Headquartered in the wisdom city of Tianhe District in Guangzhou, the company has gathered nearly 800 biomedical R&D talents and registered legislative experts with an area of nearly 3000 square meters. The company owns 9 wholly-owned subsidiaries with different business and more than 10 holding and shareholding companies.

The one-stop service provided by Boji includes approval of new drugs project and activity screening, pharmaceutical research of active pharmaceutical ingredient (API) and preparations, drug evaluation (pharmacodynamics, toxicology). Besides, clinical research, sino American (registration service), contract development & manufacturing organization (CDMO), the commercialization of technology achievements are included, covering all stages of new drug research and development.

MORE +
Industry Status
Industry Status
Domestic cro leader, providing high-quality and efficient services
01
International Service Capability
Domestic high-tech enterprises, can undertake international multi-center clinical trials and research of multinational pharmaceutical companies.
02
High-quality and Efficient Service Strength
A high-quality and efficient CRO with the most domestic customers, the most completed projects and the most approved projects.
03
One-stop Shop for Full-process CRO Service
One of the largest and most comprehensive CROs in China that grasps the industry dynamics, meets the full range of customer needs for drug R&D and ensures the continuity and stability of services.
04
Company status is recognized in the industry
Chairman Unit of Contract Research Organization Union
Chairman Unit of China Quality Association for Pharmaceuticals CRO Chapter
Vice President and Secretary General Unit of Guangdong Bio-pharmaceutical Innovat Technology Association
Director Unit of All-China Federation of Industry and Commerce Medical Pharmaceutical Chamber
Executive director Unit of Professional Committee on post-marketing re-evaluation of traditional Chinese medicine of World Federation of Societies of Traditional Chinese medicine
Company Culture
Company Culture
Corporate Philosophy
Corporate Philosophy
Corporate Philosophy

Honest and trustworthy,
professional authority,
make progress with Customers.

  • Management Concept
    Management Concept

    Service is fundamental, quality is life.

  • Strategic Objectives
    Strategic Objectives

    Consolidate domestic leadership, achieve international leadership and build a century-old brand.

  • Business Philosophy
    Business Philosophy

    Think for customers, serve customers and make progress together with customers.

  • Corporate Vision
    Corporate Vision

    Build a professional, honest, enterprising and harmonious Boji family.

Development History
Development History
Customer&Partner
Customer&Partner

Medtronic

Cosunter

ABBOTT

Pfizer

GPHL

GUANHAO BIOTECH

Mayinglong

Harbin

Xiuzheng Pharma

Tong Ren Tong

Lukang

Joincare

Pien Tze Huang

Sihuan Pharma

Dong-E-E-Jiao

Buchang Pharma

Oracle

Guangzhou Wondfo

He Zhong

Guizhou Bailing

Baiyu pharma

Topfond Pharma

Timehome Pharma

Tianan Pharma

Peking University

Sun Yat-sen University

Yipinhong Pharmacy

Jinan University

Jingxin Pharma

Xintong Pharmacy

Dawnrays

Credit Pharma

Shuangding Pharma

Shenzhen Kexing

Chemo Wanbang

Micurx Pharma

Certifcate
Certifcate
Team Background
Team background
Partner
Partner

Boji Pharmaceutical Research Center

Beijing Zhongwei Bicheng International Pharmaceutical Technology Co., Ltd.

Shanghai Pharmacies Pharmaceutical Biotechnology Co., Ltd.

Guangzhou Jiutai Medicine Technology Co., Ltd.

Xuhui Analysis Co., Ltd.

Humphries Pharmaceutical Consulting Co., Ltd.

Sermed Pharmaceutical Technology Development Co., Ltd.

Beijing Bohuikang Data Technology Co., Ltd.

Guangzhou Boyan Medical Information Technology Co., Ltd.

Guangzhou Bojitang Medicine & Health Co., Ltd.

Guangzhou Kangyuan Pharmaceutical Technology Co., Ltd.

Nanjing Hewo Pharmaceutical Co., Ltd.

Shanghai Yangguan Pharmaceutical Co., Ltd.

Hongkong Yonghe Technology Co., Ltd.

Guangzhou Shiji Medical Technology Co., Ltd.

Guangzhou Meiji Clinical Research Co., Ltd.

Zhaoqing Dingyuan Biological Medicine Co., Ltd.

Guangzhou Boji Biomedical Technology Park Co., Ltd.

Tibet Boji Investment Management Co., Ltd.

Nanjing Anmeixin Pharmaceutical Technology Co., Ltd.

  • Phone:400-0020-628
  • Address:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer